Up To 50 SAR OFF Your First Order Use Code : APP50 | Get Free Delivery With No Minimum Order

Frequently bought together
FALLAH 100/MG FC TAB 4/FC TAB
- Sku : I-022912
Key features
FALLAH 100 mg film-coated tablets contain sildenafil and are a prescription medicine in tablet form. It works by selectively inhibiting PDE5, helping increase blood flow to the penis in response to sexual stimulation. It is used for the treatment of erectile dysfunction in adult men. This pack contains 4 film-coated tablets.- Brand: FALLAH
- Active Ingredient: SILDENAFIL
- Strength: 100mg
- Dosage Form: Film-coated tablet
- Pack Size: 4 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Sexual Health
- Pharmacological Group: PDE5 Inhibitors
- Drug Class: PDE5 Inhibitor
- Manufacturer: Jazeera Pharmaceutical Industries (JPI)
- Country of Origin: Saudi Arabia
- SFDA Registration No.: 0908222452
- Shelf Life: 24 months
- Storage: store below 25°c
- Mechanism: PDE5 Inhibitor
- Onset Time: 30-60 minutes
Frequently bought together
Indications
Approved Uses
Erectile dysfunction in adult men
Dosage & Administration
Dosing by Condition
Erectile dysfunction: Initial 50 mg approximately 1 hour before sexual activity; may adjust to 25 mg or 100 mg based on response; max 100 mg per dose, once daily
Initial Dose
50 mg approximately 30-60 minutes before sexual activity (for erectile dysfunction)
Maintenance Dose
25-100 mg as needed, not more than once per day
Maximum Dose
100 mg per dose, once daily
Children's Dosage
Not approved for children
Dose Adjustment Notes
Reduce initial dose to 25 mg in elderly (>65 years), hepatic impairment, severe renal impairment (CrCl <30 mL/min), or concurrent use of CYP3A4 inhibitors
How to Take
Swallow tablet whole with water approximately 30-60 minutes before sexual activity. Can be taken with or without food, but avoid high-fat meals as they delay onset.
Side Effects
Common Side Effects
Headache, Flushing, Dyspepsia, Nasal congestion, Dizziness, Visual disturbances (color tinge, blurred vision), Back pain, Myalgia
Safety & Warnings
Contraindications
Concurrent use of nitrates or nitric oxide donors, Concurrent use of guanylate cyclase stimulators (e.g., riociguat), Severe hepatic impairment, Recent stroke or myocardial infarction (within 6 months), Severe hypotension (BP <90/50 mmHg), Hereditary degenerative retinal disorders (e.g., retinitis pigmentosa), Hypersensitivity to sildenafil
Warnings & Precautions
Use with caution in patients with cardiovascular disease; assess cardiac risk before prescribing. Avoid in patients with anatomical penile deformity (Peyronie's disease) or conditions predisposing to priapism (sickle cell anemia, multiple myeloma, leukemia). Discontinue immediately if sudden vision or hearing loss occurs. Not indicated for use in women (except PAH indication). Avoid recreational use or use without medical supervision.
Age Restriction
Not approved under 18 years
Drug Interactions
Drug Interactions
Nitrates (absolute contraindication - severe hypotension), Riociguat (absolute contraindication), Alpha-blockers (additive hypotension), CYP3A4 inhibitors - ketoconazole, itraconazole, ritonavir, erythromycin (increased sildenafil levels), CYP3A4 inducers - rifampicin (decreased sildenafil levels), Antihypertensives (additive hypotension), Cimetidine (increased sildenafil exposure)
Interaction Severity
MAJOR: Nitrates (severe life-threatening hypotension), Riociguat (severe hypotension - absolute contraindication), Ritonavir and strong CYP3A4 inhibitors (markedly increased sildenafil exposure). MODERATE: Alpha-blockers (additive hypotension), Antihypertensives (additive hypotension), Erythromycin/ketoconazole (increased sildenafil levels). MINOR: Cimetidine (modest increase in sildenafil exposure), Rifampicin (reduced sildenafil efficacy)
Food Interaction
Take on empty stomach or with a light meal; high-fat meals delay absorption and reduce peak plasma concentration
Special Populations
Pregnancy
Consult Doctor
Breastfeeding
Consult Doctor
Children
Not approved for children
Elderly
Start with 25 mg initial dose due to reduced clearance; titrate based on response and tolerability
Kidney Impairment
CrCl ≥30 mL/min: No adjustment needed. CrCl <30 mL/min or end-stage renal disease: Start with 25 mg initial dose
Liver Impairment
Mild-to-moderate (Child-Pugh A or B): Start with 25 mg initial dose. Severe (Child-Pugh C): Contraindicated
Storage & Patient Advice
Missed Dose
Used on an as-needed basis; take approximately 30-60 minutes before sexual activity. Do not take more than one dose in 24 hours.
Stopping the Medicine
Safe to stop anytime; no tapering required
Patient Counseling
Take this tablet 30 to 60 minutes before sexual activity. Sexual stimulation is required for the medication to work. Do not take more than one tablet in 24 hours. Avoid grapefruit juice and high-fat meals before taking this medication. Never take this medication with nitrate drugs (e.g., nitroglycerin) as this can cause a dangerous drop in blood pressure. Stop the medication and seek immediate medical attention if you experience sudden vision loss, sudden hearing loss, or an erection lasting more than 4 hours. Inform your doctor of all medications you are taking, especially blood pressure medications.
Monitoring Requirements
No routine monitoring required for erectile dysfunction use; monitor blood pressure in patients on antihypertensives or alpha-blockers
Pharmacology
Mechanism of Action
Selectively inhibits phosphodiesterase type 5 (PDE5), preventing degradation of cyclic GMP (cGMP) in corpus cavernosum smooth muscle, leading to smooth muscle relaxation, increased blood flow, and penile erection in response to sexual stimulation
Onset of Action
30-60 minutes
Metabolism
Hepatic via CYP3A4 (major) and CYP2C9 (minor); active metabolite N-desmethylsildenafil
Product Information
Available Dosage Forms
Film-coated tablet
Composition per Dose
Each film-coated tablet: 100 mg sildenafil (as sildenafil citrate)
Generic Availability
Yes
OTC Alternatives
No OTC alternative
Mechanism
PDE5 Inhibitor
Onset Time
30-60 minutes
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)












